Urea Cycle- Enzymes and Steps
The urea cycle is a series of biochemical reactions that produces urea from ammonia. Urea is a less toxic substance that can be excreted by the kidneys. The urea cycle is essential for animals that cannot easily and safely remove nitrogen as ammonia, such as mammals and amphibians.
The urea cycle takes place primarily in the liver, which is the main organ responsible for detoxifying ammonia and converting it to urea . However, the urea cycle is not confined to a single cellular compartment. It involves both the cytosol and the mitochondria of hepatocytes, which are the liver cells .
The first reaction of the urea cycle occurs in the mitochondria, where ammonia is converted to carbamoyl phosphate by the enzyme carbamoyl phosphate synthetase I. This reaction requires two ATP molecules and bicarbonate. Carbamoyl phosphate then reacts with ornithine, a non-protein amino acid, to form citrulline. This reaction is catalyzed by ornithine transcarbamoylase, another mitochondrial enzyme. Citrulline is then transported to the cytosol in exchange for ornithine, which re-enters the mitochondria for another round of the cycle.
The remaining three reactions of the urea cycle occur in the cytosol. Citrulline combines with aspartate, another amino acid, to form argininosuccinate. This reaction requires one ATP molecule and is catalyzed by argininosuccinate synthetase. Argininosuccinate then splits into arginine and fumarate by the action of argininosuccinate lyase. Fumarate can enter the citric acid cycle or be converted to malate and then to glucose or aspartate. Arginine is cleaved by arginase, a cytosolic enzyme, to produce urea and ornithine. Urea is then released into the blood stream and transported to the kidneys for excretion. Ornithine is transported back to the mitochondria to complete the cycle.
The urea cycle is thus partly cytoplasmic and partly mitochondrial. It involves five enzymes and four intermediates. It also interacts with other metabolic pathways, such as amino acid metabolism and citric acid cycle. The urea cycle is a vital process for maintaining nitrogen balance and preventing ammonia toxicity in animals that use this cycle.
The urea cycle uses four main substrates to produce urea from ammonia and carbon dioxide. These substrates are:
- Ammonia (NH3): This is the main source of nitrogen for the urea cycle. Ammonia is derived from the oxidative deamination of glutamate, which is catalyzed by glutamate dehydrogenase. Ammonia is also produced by other amino acid catabolic pathways and by gut bacteria. Ammonia is highly toxic and must be quickly converted to a less harmful form.
- Carbon dioxide (CO2): This is the source of carbon for the urea cycle. Carbon dioxide is produced by various metabolic processes, such as the citric acid cycle and fatty acid oxidation. Carbon dioxide reacts with ammonia to form carbamoyl phosphate, which is the first intermediate of the urea cycle.
- Aspartate: This is another source of nitrogen for the urea cycle. Aspartate is an amino acid that can be synthesized from oxaloacetate, which is an intermediate of the citric acid cycle. Aspartate provides the second nitrogen atom for the synthesis of argininosuccinate, which is the precursor of arginine and fumarate.
- Three ATP: These are the energy sources for the urea cycle. Three molecules of ATP are required for each molecule of urea produced. Two ATP are used to synthesize carbamoyl phosphate from ammonia and carbon dioxide, and one ATP is used to condense citrulline and aspartate to form argininosuccinate.
These substrates are consumed and regenerated by the urea cycle in a cyclic manner. The urea cycle also produces fumarate, which can enter the citric acid cycle and generate more oxaloacetate and aspartate. The urea cycle is thus linked to other metabolic pathways that provide or utilize its substrates.
The urea cycle is the metabolic pathway that transforms nitrogen to urea for excretion from the body. Nitrogenous excretory products are removed from the body mainly in the urine. Ammonia, which is very toxic in humans, is converted to urea, which is nontoxic, very soluble, and readily excreted by the kidneys.
The urea cycle involves five main steps: one mitochondrial and four cytosolic. The cycle consumes two molecules of ammonia, one molecule of carbon dioxide, and three molecules of ATP. The cycle produces one molecule of urea, one molecule of fumarate, two molecules of ADP, one molecule of AMP, and four molecules of inorganic phosphate.
The products of the urea cycle have different fates in the body. Urea is the main product and accounts for about 90% of the nitrogen-containing components of urine. Urea is transported from the liver to the kidneys by the blood and is filtered out by the nephrons. Urea is then concentrated in the urine by a countercurrent exchange system that also conserves water.
Fumarate is another product of the urea cycle that links it with the citric acid cycle. Fumarate can be converted to malate and then to oxaloacetate, which can be transaminated to aspartate. Aspartate can then re-enter the urea cycle as a substrate or be used for other purposes such as amino acid synthesis. Alternatively, fumarate can be converted to succinate and enter the citric acid cycle for energy production.
The other products of the urea cycle are mostly involved in energy metabolism. ADP and AMP are phosphorylated to ATP by substrate-level phosphorylation or oxidative phosphorylation. Inorganic phosphate is used for ATP synthesis or as a buffer for pH regulation.
The urea cycle consists of five reactions that convert ammonia and carbon dioxide into urea, which is then excreted by the kidneys. The cycle also produces fumarate, which can be used for gluconeogenesis or the citric acid cycle. The cycle involves both mitochondrial and cytosolic enzymes and requires four molecules of ATP per molecule of urea. The steps are as follows:
Carbamoyl phosphate synthesis: In the mitochondrial matrix, ammonia (NH3) and bicarbonate (HCO3-) are combined to form carbamoyl phosphate (CP) in a reaction catalyzed by carbamoyl phosphate synthetase I (CPS I). This is the rate-limiting and regulated step of the cycle. CPS I requires two molecules of ATP and is activated by N-acetylglutamate (NAG), which is synthesized from glutamate and acetyl-CoA. NAG levels reflect the availability of amino acids and ammonia in the liver.
Ornithine transcarbamoylation: In the mitochondrial matrix, ornithine (Orn) reacts with CP to form citrulline (Cit) in a reaction catalyzed by ornithine transcarbamoylase (OTC). This reaction releases one molecule of inorganic phosphate (Pi). Cit is then transported to the cytosol in exchange for Orn.
Argininosuccinate synthesis: In the cytosol, Cit condenses with aspartate (Asp) to form argininosuccinate (AS) in a reaction catalyzed by argininosuccinate synthetase (ASS). This reaction requires one molecule of ATP and produces one molecule of AMP and one molecule of pyrophosphate (PPi).
Argininosuccinate cleavage: In the cytosol, AS is cleaved into arginine (Arg) and fumarate (Fum) in a reaction catalyzed by argininosuccinate lyase (ASL). Fum can be converted to malate (Mal) by fumarase, and Mal can either enter the citric acid cycle or be converted to oxaloacetate (OAA) by malate dehydrogenase. OAA can then be transaminated to Asp by aspartate aminotransferase, thus regenerating the substrate for step 3.
Urea formation: In the cytosol, Arg is hydrolyzed into urea (Urea) and Orn in a reaction catalyzed by arginase (Arg). Urea is then transported to the blood and excreted by the kidneys. Orn is transported back to the mitochondria in exchange for Cit, thus completing the cycle.
The net equation for the urea cycle is:
2 NH3 + CO2 + 3 ATP + H2O → Urea + 2 ADP + 4 Pi + AMP + PPi
The urea cycle is tightly coupled with the citric acid cycle, as Fum and Mal are intermediates of both cycles. The urea cycle also links with gluconeogenesis, as Fum and OAA can be used for glucose synthesis. The urea cycle also interacts with other metabolic pathways, such as amino acid metabolism, purine and pyrimidine synthesis, and nitric oxide production.
The urea cycle involves five enzymes that catalyze the conversion of ammonia and carbon dioxide into urea and water. These enzymes are:
Carbamoyl phosphate synthetase I (CPS I): This enzyme is located in the mitochondrial matrix and is responsible for the first and rate-limiting step of the urea cycle. It uses two molecules of ATP to combine ammonia and bicarbonate into carbamoyl phosphate, which is then transferred to ornithine to form citrulline. CPS I is activated by N-acetylglutamate, which is synthesized from acetyl-CoA and glutamate by N-acetylglutamate synthase. N-acetylglutamate levels are regulated by the availability of arginine, which acts as an allosteric activator of N-acetylglutamate synthase.
Ornithine transcarbamoylase (OTC): This enzyme is also located in the mitochondrial matrix and catalyzes the second step of the urea cycle. It condenses ornithine and carbamoyl phosphate to form citrulline, which is then transported to the cytosol in exchange for ornithine. OTC is not regulated by any specific mechanism, but its activity depends on the availability of its substrates.
Argininosuccinate synthetase (ASS): This enzyme is found in the cytosol and catalyzes the third step of the urea cycle. It uses one molecule of ATP to join citrulline and aspartate into argininosuccinate, which is then cleaved by argininosuccinate lyase to form arginine and fumarate. ASS is inhibited by its product, argininosuccinate, and by high levels of ATP.
Argininosuccinate lyase (ASL): This enzyme is also found in the cytosol and catalyzes the fourth step of the urea cycle. It splits argininosuccinate into arginine and fumarate, which can enter the citric acid cycle or be converted to malate and then to glucose or oxaloacetate. ASL is not regulated by any specific mechanism, but its activity depends on the availability of its substrate.
Arginase (ARG): This enzyme is mainly located in the liver cytosol and catalyzes the final step of the urea cycle. It hydrolyzes arginine into urea and ornithine, which can be recycled back into the cycle or used for other purposes. ARG is inhibited by ornithine and by high levels of urea.
These enzymes work together to ensure that excess ammonia is efficiently converted into a less toxic form and excreted from the body. Any defect in these enzymes can lead to hyperammonemia, a condition characterized by elevated blood ammonia levels and neurological symptoms. The most common cause of hyperammonemia is a deficiency in OTC, which accounts for about 50% of all cases of urea cycle disorders. Other causes include deficiencies in CPS I, ASS, ASL, or ARG, as well as mutations in N-acetylglutamate synthase or transporter proteins involved in ornithine or citrulline transport. Treatment options for hyperammonemia include dietary restriction of protein intake, administration of drugs that enhance nitrogen excretion or reduce ammonia production, and liver transplantation in severe cases.
The urea cycle is regulated by several factors, including the availability of substrates, the activity of enzymes, and the feedback inhibition of intermediates. The main regulatory point is the first reaction of the cycle, catalyzed by carbamoyl phosphate synthetase I (CPS I). This enzyme converts ammonium and bicarbonate into carbamoyl phosphate, using two molecules of ATP. This reaction is stimulated by N-acetylglutamate (NAG), which is synthesized from acetyl-CoA and glutamate by N-acetylglutamate synthase (NAGS). NAGS is activated by arginine, which is an indicator of high nitrogen levels in the body. Therefore, when there is excess nitrogen from amino acid catabolism, NAGS produces more NAG, which in turn activates CPS I and increases the rate of urea synthesis.
Another factor that regulates the urea cycle is the availability of aspartate, which is required for the third reaction of the cycle, catalyzed by argininosuccinate synthetase (ASS). This enzyme condenses citrulline and aspartate to form argininosuccinate, using one molecule of ATP. Aspartate is synthesized from oxaloacetate by transamination with glutamate, catalyzed by aspartate aminotransferase (AST). Oxaloacetate can be derived from fumarate, which is produced in the fourth reaction of the cycle, catalyzed by argininosuccinate lyase (ASL). This enzyme splits argininosuccinate into arginine and fumarate. Therefore, there is a link between the urea cycle and the citric acid cycle, as fumarate can enter the latter and be converted to oxaloacetate. Alternatively, fumarate can be reduced to malate by fumarase, and malate can be oxidized to oxaloacetate by malate dehydrogenase. Both reactions occur in the mitochondria and are reversible.
The activity of the enzymes of the urea cycle can also be influenced by hormonal and dietary factors. For example, glucagon and glucocorticoids can induce the expression of CPS I and other urea cycle enzymes, while insulin can inhibit their expression. Moreover, a high-protein diet can increase the levels of urea cycle enzymes by stimulating their synthesis and decreasing their degradation. Conversely, a low-protein diet can decrease the levels of urea cycle enzymes by inhibiting their synthesis and increasing their degradation.
Finally, some intermediates of the urea cycle can exert feedback inhibition on the enzymes that produce them. For example, ornithine can inhibit arginase, which cleaves arginine into urea and ornithine in the last reaction of the cycle. This prevents excessive accumulation of ornithine and ensures a balance between ornithine and arginine levels in the cell. Similarly, citrulline can inhibit ornithine transcarbamoylase (OTC), which combines ornithine and carbamoyl phosphate to form citrulline in the second reaction of the cycle. This prevents excessive accumulation of citrulline and ensures a balance between citrulline and ornithine levels in the mitochondria.
In summary, the urea cycle is regulated by several mechanisms that ensure an optimal rate of urea synthesis according to the nitrogen status of the body. The main regulatory point is CPS I, which is stimulated by NAG and inhibited by its product carbamoyl phosphate. The availability of aspartate also affects the rate of urea synthesis, as it is required for ASS to produce argininosuccinate. The activity of urea cycle enzymes can be modulated by hormonal and dietary factors that reflect the metabolic state of the organism. Finally, some intermediates of the urea cycle can inhibit their own synthesis by feedback inhibition on specific enzymes.
The urea cycle allows for the excretion of NH4+ by transforming ammonia into urea, which is then excreted by the kidneys. This is important because ammonia is very toxic to the body, especially to the central nervous system. Ammonia can disrupt the pH balance of the blood and interfere with neurotransmission. Therefore, it must be removed quickly and efficiently from the body.
The urea cycle is one of the major pathways for nitrogen disposal in mammals. Nitrogen is derived from amino acids, which are obtained from dietary protein or from protein turnover in the body. Amino acids can be used for various purposes, such as energy production, synthesis of nucleotides, hormones, and other biomolecules, or conversion to glucose or ketone bodies. However, when there is an excess of amino acids or a need to conserve glucose, amino acids are degraded and their nitrogen is released as ammonia.
The urea cycle converts ammonia into urea, which is a less toxic and more water-soluble compound than ammonia. Urea contains two nitrogen atoms per molecule, whereas ammonia contains only one. Therefore, urea is a more efficient way of transporting and excreting nitrogen than ammonia. Urea is produced in the liver and transported to the kidneys via the blood. The kidneys filter out urea from the blood and excrete it in urine. The amount of urea excreted depends on the dietary protein intake and the metabolic state of the body.
The urea cycle also plays a role in maintaining acid-base balance in the body. The production of urea consumes hydrogen ions (H+), which are derived from bicarbonate (HCO3-) and ammonium (NH4+). This helps to prevent metabolic acidosis, which can occur when there is an excess of H+ in the blood. The urea cycle also generates fumarate, which can be converted to malate and then to oxaloacetate in the cytosol. Oxaloacetate can be transaminated to aspartate, which can re-enter the urea cycle or be used for gluconeogenesis. This helps to maintain glucose homeostasis and prevent hypoglycemia.
The urea cycle is essential for life and health in mammals. It allows for the safe and efficient removal of excess nitrogen from the body and contributes to acid-base and glucose balance. Without the urea cycle, ammonia would accumulate in the blood and cause severe neurological damage and death.
Urea cycle disorders (UCDs) are a group of rare genetic conditions that affect how the body removes ammonia, a waste product of protein metabolism, from the blood. Ammonia is toxic and can cause brain damage or death if it accumulates in the blood . UCDs are caused by defects in one of the six enzymes or two transporters that convert ammonia to urea, which is excreted by the kidneys . UCDs can present at any age, but newborns with severe mutations can become very sick within days of birth . UCDs are treated by limiting protein intake and taking medications or supplements.
There are eight types of UCDs identified by the lack or malfunction (deficiency) of certain enzymes and proteins in the urea cycle :
- N-acetylglutamate synthase (NAGS) deficiency
- Carbamoylphosphate synthetase I (CPS1) deficiency
- Ornithine transcarbamoylase (OTC) deficiency
- Argininosuccinate synthase 1 (ASS1) deficiency or Citrullinemia type I
- Citrin deficiency or Citrullinemia type II
- Argininosuccinic lyase (ASL) deficiency
- Arginase (ARG) deficiency
- Ornithine translocase deficiency
UCDs are inherited diseases that are passed down from parents to children through defective genes . Most UCDs are autosomal recessive, meaning that a child must inherit two copies of the defective gene, one from each parent, to have the disease. One UCD, OTC deficiency, is X-linked, meaning that it is caused by a defective gene on the X chromosome and mostly affects males.
The symptoms of UCDs vary depending on the type and severity of the disorder, but they generally involve neurological and behavioral problems due to high levels of ammonia in the blood . Some common symptoms include:
- Poor feeding and growth
- Vomiting and diarrhea
- Lethargy and irritability
- Seizures and coma
- Developmental delay and intellectual disability
- Learning difficulties and attention deficit hyperactivity disorder (ADHD)
- Mood swings and psychosis
- Headache and blurred vision
The diagnosis of UCDs is based on clinical signs, blood and urine tests, genetic testing, and sometimes liver biopsy . The treatment of UCDs aims to reduce ammonia levels in the blood and prevent further damage to the brain and other organs. The main strategies include:
- Dietary restriction of protein intake to avoid excess ammonia production
- Medications or supplements that enhance urea synthesis or provide alternative pathways for nitrogen disposal
- Dialysis or hemofiltration to remove ammonia from the blood in acute crises
- Liver transplantation to restore normal urea cycle function in some cases
The prognosis of UCDs depends on the type and severity of the disorder, the age of onset, the promptness of diagnosis and treatment, and the occurrence of complications . Some UCDs can be managed well with diet and medications, while others may require more intensive interventions. Early detection and treatment can improve the outcome and quality of life for people with UCDs.
We are Compiling this Section. Thanks for your understanding.